Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

SARS-CoV-2 Nucleocapsid antibody

SARS-CoV-2 N Reactivity: SARS Coronavirus-2 (SARS-CoV-2), Virus ELISA, WB Host: Mouse Monoclonal 1C7 unconjugated
Catalog No. ABIN6952435
  • Target See all SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N) Antibodies
    SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N)
    Reactivity
    • 59
    • 11
    • 4
    • 3
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    SARS Coronavirus-2 (SARS-CoV-2), Virus
    Host
    • 30
    • 16
    • 15
    • 4
    • 1
    • 1
    Mouse
    Clonality
    • 51
    • 10
    • 5
    Monoclonal
    Conjugate
    • 49
    • 9
    • 5
    • 2
    • 1
    This SARS-CoV-2 Nucleocapsid antibody is un-conjugated
    Application
    • 56
    • 25
    • 11
    • 7
    • 6
    • 3
    • 3
    • 3
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    ELISA, Western Blotting (WB)
    Purification
    Purified by Protein G.
    Immunogen
    Recombinant SARS-CoV-2 N protein (His-tag)
    Clone
    1C7
    Isotype
    IgG2b
  • Application Notes
    WB 1:300-1000
    ELISA 1:500-1000
    Restrictions
    For Research Use only
  • Format
    Liquid
    Concentration
    1 μg/μL
    Buffer
    Aqueous buffered solution containing 0.01M PBS( pH 7.4) with 0.1 % Proclin300.
    Preservative
    ProClin
    Precaution of Use
    This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
    Storage
    -20 °C
    Storage Comment
    Store at -20 °C
    Expiry Date
    12 months
  • Sperber, Sutter, Müller, Müller, Schwarzer: "The Bovine Seminal Plasma Protein PDC-109 Possesses Pan-Antiviral Activity." in: Viruses, Vol. 14, Issue 9, (2022) (PubMed).

    Le-Trilling, Mennerich, Schuler, Sakson, Lill, Kasarla, Kopczynski, Loroch, Flores-Martinez, Katschinski, Wohlgemuth, Gunzer, Meyer, Phapale, Dittmer, Sickmann, Trilling: "Identification of herbal teas and their compounds eliciting antiviral activity against SARS-CoV-2 in vitro." in: BMC biology, Vol. 20, Issue 1, pp. 264, (2022) (PubMed).

    Wenzek, Steinbach, Wirsdörfer, Sutter, Boehme, Geffers, Klopfleisch, Bruder, Jendrossek, Buer, Westendorf, Knuschke: "CD47 restricts antiviral function of alveolar macrophages during influenza virus infection." in: iScience, Vol. 25, Issue 12, pp. 105540, (2022) (PubMed).

    Krempe, Schöler, Katschinski, Herrmann, Anastasiou, Elsner, Ross, Scholz, Dittmer, Miethe, Le-Trilling, Trilling: "A rapid test recognizing mucosal SARS-CoV-2-specific antibodies distinguishes prodromal from convalescent COVID-19." in: iScience, Vol. 24, Issue 10, pp. 103194, (2021) (PubMed).

    Schöler, Le-Trilling, Eilbrecht, Mennerich, Anastasiou, Krawczyk, Herrmann, Dittmer, Trilling: "A Novel In-Cell ELISA Assay Allows Rapid and Automated Quantification of SARS-CoV-2 to Analyze Neutralizing Antibodies and Antiviral Compounds." in: Frontiers in immunology, Vol. 11, pp. 573526, (2020) (PubMed).

    Chen, Juric, Cosgrove, Bowman, Fitzpatrick, Schoech, Clark, Coop: "Allele frequency dynamics in a pedigreed natural population." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 116, Issue 6, pp. 2158-2164, (2019) (PubMed).

  • Target
    SARS-CoV-2 Nucleocapsid (SARS-CoV-2 N)
    Alternative Name
    SARS-CoV-2 N protein (SARS-CoV-2 N Products)
    Synonyms
    nucleocapsid phosphoprotein antibody, N antibody
    Target Type
    Viral Protein
    UniProt
    P0DTC9
You are here:
Support